OrbusNeich Medical Group Holdings Limited (FRA:Q8T)

Market Cap	330.50M -4.6%
Revenue (ttm)	153.69M +10.0%
Net Income	35.69M +5.5%
EPS	0.04 +5.6%
Shares Out	n/a
PE Ratio	9.26
Forward PE	8.87
Dividend	0.03 (8.16%)
Ex-Dividend Date	Sep 18, 2025

Volume	n/a
Average Volume	11
Open	0.3440
Previous Close	0.3400
Day's Range	0.3440 - 0.3440
52-Week Range	0.2940 - 0.6550
Beta	n/a
RSI	49.17
Earnings Date	Mar 12, 2026

About FRA:Q8T

OrbusNeich Medical Group Holdings Limited, an investment holding company, engages in the manufacture, trading, sale, and marketing of medical devices/instruments for the treatment of coronary and peripheral vascular diseases. The company offers semi-compliant balloons and scoring balloons for pre-dilatation and lesion preparation, stents for implantation, non-compliant balloons for post-dilatation, and specialty catheters, as well as drug coated balloon, microcatheters, guide catheter extension, dual therapy, drug eluting stents, and self-expan...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 2001
• Employees: 1,477
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: Q8T

Financial Performance

In 2025, FRA:Q8T's revenue was $180.45 million, an increase of 9.97% compared to the previous year's $164.10 million. Earnings were $41.90 million, an increase of 5.49%.

Financial numbers in USD